Form 4: Lucid Diagnostics Director Ronald M. Sparks Acquires 112,800 Shares of Common Stock

Director Ronald M. Sparks acquired 112,800 shares of Lucid Diagnostics Inc. common stock on February 20, 2025, as part of a restricted stock grant.

Summary

• On February 20, 2025, Ronald M. Sparks, a director of Lucid Diagnostics Inc., acquired 112,800 shares of common stock.
• The acquisition was a grant of restricted stock under the Issuer's 2018 Equity Plan.
• The restricted stock has a single vesting date of May 20, 2028, and is subject to forfeiture if the required service period is not completed.
• Following the transaction, Sparks directly owns 197,460 shares of Lucid Diagnostics Inc. common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a director is generally viewed as a positive sign, indicating confidence in the company's prospects. However, it's a routine transaction and doesn't necessarily indicate a major shift in the company's outlook.

Positives

• The grant of restricted stock aligns the director's interests with the long-term performance of the company.
• Increased share ownership by a director can signal confidence in the company's future prospects.

Risks

• The restricted stock is subject to forfeiture if the service requirements are not met, which could impact the director's motivation.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting of the restricted stock on May 20, 2028, suggests a long-term commitment from the director.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the ownership structure and alignment of interests between management and shareholders.

Stakeholder Impact

• Shareholders may view the increased ownership by a director as a positive signal.
• Employees may see it as a sign of confidence in the company's future.

Key Dates